Good news for anyone suffering from the discomfort and distress caused by rosacea—a recent study into Colorescience products is set to guarantee more converts to the mineral make-up brand, originally developed for post-procedure care. The Journal of Cosmetic Dermatology
undertook an 18-week study into the efficacy and tolerability of a daily use, multifunctional topical skincare regime using All Calm Clinical Redness Corrector SPF 50 and Sunforgettable Brush-On Shield SPF 50, alone and in combination with Intense Pulsed Light Therapy (IPL), to improve facial redness associated with skin conditions such as rosacea and decrease post-treatment side effects.
"Our mission is to develop unique products that improve patient experiences, enhance outcomes and protect skin health," said Patricia Boland, Colorescience Vice President, Research and Development. "We are pleased that these results are consistent with our other published data and what our physician partners see in practice."
Clinical study investigator, Jennifer Deaver Peterson, MD of The Pearl Dermatology in Houston, TX, said, "The study showed that this regime can achieve significant improvement for patients who suffer with facial redness. Having products like these that work alone or in combination with office-based procedures is a game-changer for aesthetic practices."About the clinical study
Twenty patients used a daily topical skincare regime for 12 weeks. At week 12, those same patients received a single IPL (M22 Lumenis) treatment immediately followed by the application of the same skincare products and then continued the topical skincare regime for six additional weeks.